ASHERBIO
Live / Registered — Registered (as of 23 May 2023)
What this means for you
Registered since 23 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90694701
- Registration number
- 7062914
- Mark type
- Word mark
- Filed
- 06 May 2021
- Published for opposition
- 15 Feb 2022
- Registered
- 23 May 2023
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of viral, oncological, and immune system related diseases and disorders; Medical preparations for the treatment of viral, oncological, and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Medical research; Pharmaceutical research services; Pharmaceutical research and development; Scientific research for Medical purposes in the fields of cancerous diseases, immunotherapy, autoimmune diseases and disorders, and infectious diseases; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of cancer, immunological diseases and disorders, and infectious diseases; Research and development of immunotherapies for the treatment of cancer; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Asher Biotherapeutics, Inc., South San Francisco, CA, US
- Asher Biotherapeutics, Inc., South San Francisco, CA, US
- Asher Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 23 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Apr 2023 — USE AMENDMENT FILED
- 17 Apr 2023 — SOU EXTENSION 2 GRANTED
- 11 Apr 2023 — SOU EXTENSION 2 FILED
- 17 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2023 — TEAS STATEMENT OF USE RECEIVED
- 14 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Oct 2022 — SOU EXTENSION 1 GRANTED
- 12 Oct 2022 — SOU EXTENSION 1 FILED